GSK-GLP107085



A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin)
albiglutide
GLP107085
NCT01406262
Diabetes Mellitus, Type 2
Phase 1
 
June 2014